Cargando…
Upregulation of miR‐374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer
Breast cancer (BRCA) is the second leading cause of cancer‐related death among female worldwide. Recent studies have revealed that LACTB was frequently repressed and functioned as a bona fide new tumor suppressor in a series of cancers, including BRCA. However, the molecular mechanisms underlying LA...
Autores principales: | Zhang, Jun, He, Yuting, Yu, Yan, Chen, Xiaolong, Cui, Guangying, Wang, Weiwei, Zhang, Xiaojian, Luo, Yonggang, Li, Juan, Ren, Fang, Ren, Zhigang, Sun, Ranran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051141/ https://www.ncbi.nlm.nih.gov/pubmed/29790671 http://dx.doi.org/10.1002/cam4.1576 |
Ejemplares similares
-
LACTB, a Metabolic Therapeutic Target in Clinical Cancer Application
por: Li, Xiaohua, et al.
Publicado: (2022) -
Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer
por: Xue, Chen, et al.
Publicado: (2018) -
Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma
por: Liu, Jinlu, et al.
Publicado: (2021) -
KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis
por: Wang, Wenlong, et al.
Publicado: (2020) -
Presence of schistosome eggs in lymph node predict unfavorable prognosis in schistosomal colorectal cancer
por: Pan, Weiyu, et al.
Publicado: (2023)